SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-044360
Filing Date
2020-07-31
Accepted
2020-07-31 21:05:18
Documents
1
Period of Report
2020-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5008
  Complete submission text file 0001209191-20-044360.txt   6369
Mailing Address
Business Address
BREITMEYER JAMES B (Reporting) CIK: 0001244823 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50549 | Film No.: 201067596

Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences